CellaVision AB
STO:CEVI
CellaVision AB
Other Assets
CellaVision AB
Other Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
CellaVision AB
STO:CEVI
|
Other Assets
kr128.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Elekta AB (publ)
STO:EKTA B
|
Other Assets
kr7.5B
|
CAGR 3-Years
8%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
S
|
Surgical Science Sweden AB
STO:SUS
|
Other Assets
kr3.6B
|
CAGR 3-Years
6%
|
CAGR 5-Years
69%
|
CAGR 10-Years
N/A
|
|
|
Getinge AB
STO:GETI B
|
Other Assets
kr30.1B
|
CAGR 3-Years
15%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Arjo AB (publ)
STO:ARJO B
|
Other Assets
kr5.9B
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
S
|
Stille AB
STO:STIL
|
Other Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CellaVision AB
Glance View
CellaVision AB engages in the provision of automated microscopy systems in the field of hematology. The company is headquartered in Lund, Skane and currently employs 200 full-time employees. The company went IPO on 2007-05-28. The firm develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The firm operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
See Also
What is CellaVision AB's Other Assets?
Other Assets
128.1m
SEK
Based on the financial report for Dec 31, 2024, CellaVision AB's Other Assets amounts to 128.1m SEK.
What is CellaVision AB's Other Assets growth rate?
Other Assets CAGR 5Y
2%
Over the last year, the Other Assets growth was 4%.
You don't have any saved screeners yet